April 27, 2017
Cohero Health, a New York City-based digital health company focused on chronic respiratory disease, has a new CEO: Joe Condurso, former CEO of PatientSafe Solutions.
“We are pleased to welcome Joe to the talented team at Cohero Health,” Cohero cofounder and president Melissa Manice said in a statement. “We all share a deep passion for the use of technology to improve health care and patient...
April 18, 2017
Dublin, Ohio-based Monitored Therapeutics, Inc. (MTI) has received FDA 510(k) clearance for its connected spirometer, GoSpiro. The device, which calculates diagnostic-quality air capacity measurement, was designed specifically for use in a non-clinical setting. As calculations are performed inside the device, GoSpiro can work with any smartphone, tablet or computer without the need for separate...
March 15, 2017
New York City-based Cohero Health, which develops connected health tools and technologies for chronic respiratory diseases, has closed on $10.5 million in Series A funding. This builds on the company’s earlier $9 million Series A round from late 2016, and the extra funding comes from new strategic investors Samsung Next and Omron Healthcare. With seed funding, this brings Cohero's total funding...
November 2, 2016
Cohero Health, a New York City-based digital health company focused on chronic respiratory disease, has raised $9 million in new funding. Three Leaf Ventures, an affiliate of the Broe Group, led the round, which also included Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts and BioAdvance. GIS Strategic Ventures, the investment arm of Guardian insurance was a new...
June 30, 2016
Wing, an app-connected spirometer from St. Louis, Missouri-based Sparo Labs, is ready to take flight. The FDA recently cleared the device with an over-the-counter clearance, meaning the company can market it directly to consumers, but Sparo sees provider and pharma channels as important ones too.
With Wing, Sparo aims to help people manage asthma and other respiratory conditions, such as COPD...
November 3, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
June 2, 2015
New York City-based Cohero Health has received FDA 510(k) clearance for its mobile connected spirometer. The Bluetooth-connected device measures critical lung function with comparable accuracy to clinical-grade spirometers, and sends the data to a smartphone or tablet.
Cohero Health has already been using the spirometer as part of its medication adherence tracking platform in a pilot at Mount...